• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Discussion: Chinese Academy of Sciences (CAS) in Wuhan has been working with bats and coronavirus for many years - DNA manipulations, cloning.... - Ja

all the genbank-known sequences are still very distant from covid , including RaTG13 .
No signs for a lab-escape here

They might have found covid in pangolins or bats and kept it secret, worked with it,
maybe even manipulated the cleavage site and then it escaped.
But that's not typical for their research, which requires publishing.

They may have found the virus (in Yunnan ?), did some first testing, immediately recognised
its military potential and kept everything secret while growing it, testing it further
 
all the genbank-known sequences are still very distant from covid , including RaTG13 .
No signs for a lab-escape here

They might have found covid in pangolins or bats and kept it secret, worked with it,
maybe even manipulated the cleavage site and then it escaped.
But that's not typical for their research, which requires publishing.

They may have found the virus (in Yunnan ?), did some first testing, immediately recognised
its military potential and kept everything secret while growing it, testing it further

What possible military potential does this virus offer? It is highly infectious, but slow acting and only moderately lethal. I struggle to envision a practical military use for it.

It seems more likely that this was just another research effort to try to understand these SARS related bat viruses. We know the scientists have at times been very blase about their study subjects, even carrying deadly germs in their airplane luggage, so the possibility of a slip up at a facility is quite real.
Separately, I'd thought the virus was well over 90% identical to an earlier horseshoe bat carried specimen, but with some new sequences included which make it so dangerous. There does not yet appear to be a consensus as to where those new sequences come from.
 
to demonstrate to the world the superiority of Chinese communism with strong government over Western democracies
with freedom and reluctant public health measures.

Xi : China will be stronger than before after this (or similar)
 
they had 96% similarity with RatG13 from 2013. Not enough to assume a lab-escape, even if the escape already happened in 2013.
You can't apply these changes in a lab so to hide things - someone will discover a natural virus and the deceiving becomes obvious.

I assume that internationally the search for similar viruses in animals is being intensified now.
When you hide a virus , others may find a similar one ...

In old days they replicated the viruses through many generations in the lab and mutations were added.
Nowadays they freeze them in liquid nitrogen to preserve them (afaik, what I'd read, I'm not a lab-person)
 
Translation Google

Pneumonia outbreak: ambiguous "Patient Zero" and virus source dispute

Wang Yiqing
BBC Chinese
February 18, 2020

China is working to curb the spread of the new coronavirus pneumonia, but where exactly the outbreak has started is still foggy. A doctor who was involved in treating the first new crown patient currently known to the public told the BBC that the patient was a patient with cerebral infarction in his 70s at home.

This is the first time that information about the early patient has been made public. He is believed to have developed the disease on December 1st, almost a week earlier than the patient previously reported by Wuhan officials on December 8th. It is worth noting that he has no history of exposure to the South China seafood market.

The wildlife trade in the South China Seafood Market in Wuhan has been suspected to have been the culprit for the epidemic, but the experience of the old man is challenging that conclusion. Scholars and netizens have questioned whether the virus has other potential sources, including whether it may be related to Wuhan Virus Research Institute.

Earliest known patient
The new outbreak of coronavirus pneumonia in Wuhan, which has infected more than 70,000 people and killed nearly 2,000 people in China, remains unclear as to how the virus initially crossed the species barrier and transmitted from animals to people. The key to understanding the virus's path of transmission is the identity of the first patient and how he became infected.

The Wuhan Municipal Health and Health Commission stated in a notification that the onset of the first case of new coronary pneumonia was December 8 last year, but an international authoritative medical journal "The Lancet" published on January 24 by A thesis written by Huang Chaolin and other deputy directors of Wuhan Jinyintan Hospital, who admitted to treating patients with new coronary pneumonia, pushed the first patient's onset time to December 1. The paper was written by nearly 30 researchers in Chinese medical institutions, and a considerable number of them are working in the field of treating patients with new crowns.

Dr. Wenjuan Wu, director of the Intensive Care Unit (ICU) at Jinyintan Hospital and one of the authors of the above papers, told the BBC on Monday (February 17) that the patient who developed the disease on December 1 was a man over seventies . The onset time on December 1 was a conclusion drawn from the epidemiological survey of the family members.

"This patient has a cerebral infarction and senile dementia, and the condition was very bad when he was sent over," Wu Wenjuan said. She declined to disclose the patient's last name.

It is reported that after the onset of the disease, the patient was first admitted to another hospital in Wuhan, but as the condition worsened, he was transferred to Jinyintan Hospital on December 29. At the time, Huang Chaolin and Wu Wenjuan were on the scene.

Wu Wenjuan said the old man had been sick at home before and had not visited the South China Seafood Market, a trading market in Wuhan that sells seafood and game products. Because a large number of merchants in this market became ill at the beginning of the outbreak, it was once considered the origin of the outbreak.

"He lives far from four or five stops (bus stops) at the seafood market," Wu Wenjuan said. "And because he was sick, he basically didn't go out."

According to a paper published in The Lancet, the elderly's family members did not develop fever or respiratory symptoms after the onset of illness, and there was no epidemiological link between them and subsequent patients. Ten days after his onset, three other people developed symptoms, two of whom had no history of exposure to the South China seafood market.

The BBC has not been able to independently verify this information.

Source of contradiction

The BBC asked Wu Wenjuan, "Why is this patient who has been living at home for a long time and has never been to the South China Seafood Market infected with this newly discovered virus? Is there any other possible source of infection?"

She avoided the problem.

"What you are asking is exactly the direction of our next research," said Wu Wenjuan.

But it is obvious that this contradicts the previous widely speculated that the epidemic was a large number of operators or game buyers of the South China seafood market that transmitted the virus directly to the South China seafood market.

Huang Chaolin previously said in an interview with the Chinese media "Caixin.com": "From the perspective of the current disease situation, the seafood market is not the only source of exposure ... it is multi-source," but he believes that the virus has It is likely to still come from wild animals.

This wild animal is now generally considered a bat. As early as February 3, Nature, an international authoritative academic journal, Nature published a research paper on the origin of the new crown virus by Shi Zhengli, a researcher at the Wuhan Institute of Virology, Chinese Academy of Sciences, who believed that bats were a possible source of the pneumonia epidemic.

At a press conference on Saturday (February 15), officials from the Chinese Ministry of Science and Technology reiterated that bats are still the most likely source of the new crown virus, but pangolin may be one of the intermediate hosts of the new crown virus.

This reminds people of the SARS epidemic that prevailed in China from 2002 to 2003. In this outbreak, scientists first thought that the virus originated from civet, but eventually the disease was identified as a bat. But to this day, the first SARS patient-a chef in Heyuan, Guangdong-still insists he has not been exposed to these wild animals.

Wuhan Virus Institute in Controversy
Are there other possibilities?

The Wuhan Virus Research Institute mentioned above is a focus that has recently been questioned by public opinion. As Chinese officials have been extremely secretive about the identity of the first patient, netizens have been questioning whether the first patient was an employee of the Wuhan Virus Research Institute.

For example, last Saturday (February 15), the rumor that "Wu Yanling, a female graduate student at Wuhan Institute of Virology, is a patient with New Coronary Pneumonia No. 0" was widely circulated in Chinese social media. "Patient Zero" generally refers to the first patient who became infected with the virus and started to spread the virus.

The institute and Huang Yanling's company had a "rumor rumor" on Sunday, saying that the lady "has been working and living in other provinces since graduation." Shi Zhengli, a researcher at the institute, told the media, "None of us have been infected with the virus, and we have zero infection."

In addition, as early as the outbreak of the outbreak, a paper from the Indian Institute of Technology team questioned that the four independent inserts of the new crown virus "is unlikely to happen by accident in nature," which instantly made the outside world for "Contributing to the creation of biological and chemical weapons" conspiracy theory has been raging, but then the author of the article announced the withdrawal.

According to Rutgers University biologist Richard H. Ebright, according to the BBC, according to the current genome sequencing of the virus, there is no evidence that the virus has been artificially modified. In Nature, he expressed concern about a bat virus experiment at the Wuhan Institute of Virology.

But Eblatt added that this does not represent a possibility that the virus from the outbreak could enter the population due to a laboratory accident.

He said that genome sequencing showed that the outbreak virus was very close to the bat coronavirus RaTG13 collected in a cave in Yunnan in 2003 by the Wuhan Virus Research Institute, with a genome-wide homology of 96.2%.

"This means that the virus is currently known to exist in two places: a cave in Yunnan and a laboratory at the Wuhan Institute of Virology," Eblet said. "It has been stored at the Wuhan Institute of Virology since 2013. "

On February 14, Chinese President Xi Jinping proposed at a meeting that biosafety should be “incorporated into the national security system” and the introduction of a biosafety law be promoted as soon as possible. The next day, the Ministry of Science and Technology of China demanded “strengthening the management of laboratories, especially viruses”.

When asked if the first elderly person diagnosed had any relatives related to the Wuhan Virus Research Institute or the South China Seafood Market, Director Wu Wenjuan of Jinyintan Hospital said that "it is impossible to draw conclusions" now.

https://www.bbc.com/zhongwen/simp/chinese-news-51540821
 
Hattip Tetano

Virology Blog: Furin cleavage site in the SARS-CoV-2 coronavirus glycoprotein
Today, 12:31 PM
By Vincent Racaniello
...
Examination of the protein sequence of the S glycoprotein of SARS-CoV-2 reveals the presence of a furin cleavage sequence (PRRARS|V). The CoV with the highest nucleotide sequence homology, isolated from a bat in Yunnan in 2013 (RaTG-13), does not have the furin cleavage sequence. Because furin proteases are abundant in the respiratory tract, it is possible that SARS-CoV-2 S glycoprotein is cleaved upon exit from epithelial cells and consequently can efficiently infect other cells. In contrast, the highly related bat CoV RaTG-13 does not have the furin cleavage site.

Whether or not the furin cleavage site within the S glycoprotein of SARS-CoV-2 is actually cleaved remains to be determined. Meanwhile, it is possible that the insertion of a furin cleavage site allowed a bat CoV to gain the ability to infect humans. The furin cleavage site might have been acquired by recombination with another virus possessing that site. This event could have happened thousands of years ago, or weeks ago. Upon introduction into a human – likely in an outdoor meat market – the virus began its epidemic spread.

Furins are also known to control infection by avian influenza A viruses, in which cleavage of the HA glycoprotein is needed for entry into the cell. Low-pathogenic avian influenza viruses contain a single basic amino acid at the cleavage site in the HA protein which is cleaved by proteases that are restricted to the respiratory tract. Insertion of a furin cleavage site in the HA of highly pathogenic avian H5N1 influenza viruses leads to replication in multiple tissues and higher pathogenicity, due to the distribution of furins in multiple tissues.

Acquisition of the furin cleavage site might be viewed as a ‘gain of function’ that enabled a bat CoV to jump into humans and begin its current epidemic spread.

http://www.virology.ws/2020/02/13/fu...-glycoprotein/

https://flutrackers.com/forum/forum...te-in-the-sars-cov-2-coronavirus-glycoprotein
 
Translation Google

Scholar: New artificial pneumonia virus is highly likely

2020-02-22 14:43 Web News Agency / Taipei 22nd

Fang Qitai, a professor at the National Taiwan University School of Public Health, said today that academically , the new crown pneumonia virus may indeed be artificial, but administrative investigation is needed to reach a conclusion. In addition, if the virus is artificial, it means that there is no ecological place in nature, and the root may be broken in the future.

The Taiwan Society of Public Health held a "Newcastle Virus Public Health Community Epidemic Prevention Education Course" at the National Taiwan University today, inviting a number of public health experts to give lectures and broadcasting it on the Facebook fan page, attracting many teachers and students of public health related departments and people concerned about the epidemic Watch.

When Fang Qitai gave a lecture on "The Epidemiology of New Coronary Pneumonia," he quoted a number of viewpoints from overseas academia to discuss whether the new coronary pneumonia might be a man-made product of the laboratory and accidentally leaked out to cause disaster instead of natural evolution.

Fang Qitai said that many European and American scholars questioned that the outbreak of new crown pneumonia could not be separated from the New Crown Virus Research Institute of the Chinese Academy of Sciences. In its P4 laboratory, there are a large number of deadly viruses such as SARS and Ebola. Room culture has always been questioned.

Fang Qitai said that existing research literature pointed out that the new crown pneumonia virus and a bat virus RaTG13 retained by a new crown virus research institute have a similarity of 96%, causing academic discussion. However, from a virological point of view, 96% are not the same, and it may take more than 99% to count, but the key is the difference.

The French team compared the gene sequences and found that the new coronary pneumonia virus has 4 amino acids more than other coronaviruses, which may cause it to be more invasive, pathogenic, and transmissible than the original virus. Therefore, many people associate with it. Is it possible that some people think that SARS was too easy to be cracked 17 years ago, so they have developed an "upgraded version", and it can be done from the current technology.

Fang Qitai pointed out that most of the evolution in nature is a single point mutation, and it is unlikely that 4 amino acids will be added all at once. Therefore, academically speaking, new coronary pneumonia may indeed be artificially added in the laboratory; Sex is not without, but chances are very small.

Fang Qitai emphasized that at present, it can only be said that academically, the mutation of neo-pneumococcal pneumonia is unusual and may indeed be a man-made product. But in fact, internal administrative investigation is needed to find out laboratory records and other evidence. There are answers.

Fang Qitai believes that whether the new crown pneumonia is artificial will have an important impact on the future investigation and judgment of the epidemic. If it is an artificial virus, it means that it does not have its ecological position in nature, unlike influenza. Influenza is naturally evolved and is part of the ecology. Therefore, no one dares to say that it can block or eliminate the flu. Can reduce disasters and reduce severe deaths.

But there is no virus in nature, which means that when the last patient is cured, it can be cut off and disappear. The epidemic will eventually become a thing of the past, with the opportunity to disappear like SARS.

https://udn.com/news/story/6656/4363085
 
I had a quick look at Pangolins a few weeks ago as an intermediary host. They are genetically on a branch with cats and dogs and they have ACE2 receptors which are a close match, but ACE2 is a common to many species. However they are critically endangered with very small population size, they are secretive by nature and like a wooded hill side habitat. The main population is in the south and well away from the epicenter. While possible this makes it poor potential host, something more common, even if seldom infected, would seem more likely.

There's been rumors and this sounds like good confirmation that farming has been going on. Possibly the farming contributed but I think a human was the vector, maybe a farmer of bats or pangolins brought it to town. Even a bat researcher could have gotten infected by this in a cave.

https://www.theguardian.com/environm...-farm-industry
On a visit to Shaoguan, Guangdong province, last year, the Guardian and staff from CBCGDF saw a caged facility previously used for attempted breeding of the notoriously hard-to-breed pangolin.

While there were no longer pangolin at the site, several locals near the facility confirmed the species had been raised there, along with monkeys and other wildlife.

I did consider biotech. I don't care for all those proliferating animal labs. The best theory I could come up with based on that redacted paper about the 4 HIV sequence insertions, (gp120 and GAG?), was that this was an HIV vaccine candidate gone haywire. I found one paper from 2006 where coronaviruses were being researched as vectors to carry those HIV antigens. The research was from Europe but the primate lab in Wuhan is attracting teams from Europe because of the lax animal protection laws in China.
Still, there were no papers on the concept since then and they were considering using a mild human coronavirus. Even though common they said it would work because people don't develop protective immunity to the these viruses. But this novel virus seems too strange for anyone to have tried to use it as a vaccine vector. Why do that if a plain old cold virus will work?

So my opinion is that no sophisticated bioengineering was involved in creating this new human virus currently circulating.
 
Emily
Genetic clock data gives the date of COVID human samples all coming from a single introduction a few months ago. The same calculations show divergence from either the closest bat or pangolin sequences as a couple of decades ago. No animal host has been found carrying the decades of lost viral evolution, but it must have been evolving somewhere. There is no evidence of any human interference in this virus' evolution and where close gene sequences (like the snakes) have been found it is due to common mechanisms, and genes, of ancient origin which can be found in most current life forms. The fact that so many drug trials are going on with existing drugs for diseases as diverse as flu, HIV and SARS is due to the same common mechanisms used for cell attachment, cleavage and fusion.
 
[h=1]China will promote biosecurity law as soon as possible[/h] [h=4][/h]

March 02, 2020 23:51

Xinhua News Agency, Beijing, March 2 (Reporters: Mei Changwei, Ding Peng) Ministry of National Defense spokesman Wu Qian said at a press conference on the army ’s support to fight the new crown pneumonia epidemic on the 2nd that China will promote the introduction of the Biosafety Law as soon as possible and accelerate Establish a national biosafety law and regulation system and an institutional guarantee system.

Wu Qian said that strengthening national biosafety is a common practice in various countries, and the international community has always attached great importance to biosafety issues. In 1992, the United Nations Conference on Environment and Development adopted Agenda 21 and the Convention on Biological Diversity, which specifically addressed the issue of biosafety. From the perspective of protecting people's health, safeguarding national security, and maintaining long-term public security, China has decided to incorporate biosafety into the national security system, systematically plan the construction of national biosafety risk prevention and control systems, and comprehensively improve national biosafety governance capabilities.

"The occurrence of this epidemic has further highlighted the importance of biosafety." Wu Qian said, "China will promote the promulgation of the biosafety law as soon as possible, and accelerate the establishment of a national biosafety legal and regulatory system and institutional guarantee system."


http://legal.people.com.cn/n1/2020/0302/c42510-31613435.html
 
Rosmarina posts - requested moved off site due to family safety

[h=1]Swiss Scientists Have Recreated the Coronavirus in a Lab[/h] [h=2]A synthetic virus could help develop drugs, vaccines, and diagnostic tests but could also be used as a bioweapon[/h]
https://onezero.medium.com/swiss-scientists-have-recreated-the-coronavirus-in-a-lab-d12816bfdbe3


Giving the information above as true (I think that the lab mentioned is where I regularly send my samples to sequence…), how could be possible to publish the following article?

Shan-Lu Liu, Linda J. Saif, Susan R. Weiss & Lishan Su
(2020)
No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2,
Emerging Microbes & Infections,
9:1,
505-507,

The absence of a logical targeted pattern in the new viral sequences and a close relative in a wildlife species (bats) are the most revealing signs that SARS-CoV-2 evolved by natural evolution.

Maybe they are not aware of the "Swiss" lab ;-P
 
Swiss Scientists Have Recreated the Coronavirus in a Lab

A synthetic virus could help develop drugs, vaccines, and diagnostic tests but could also be used as a bioweapon


https://onezero.medium.com/swiss-sci...b-d12816bfdbe3


Giving the information above as true (I think that the lab mentioned is where I regularly send my samples to sequence…), how could be possible to publish the following article?
Shan-Lu Liu, Linda J. Saif, Susan R. Weiss & Lishan Su
(2020)
No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2,
Emerging Microbes & Infections,
9:1,
505-507,


The absence of a logical targeted pattern in the new viral sequences and a close relative in a wildlife species (bats) are the most revealing signs that SARS-CoV-2 evolved by natural evolution.

Maybe they are not aware of the "Swiss" lab ;-P


This is the paper referred to above:
Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

Tran Thi Nhu Thao, Fabien Labroussaa, Nadine Ebert, Philip V’kovski, Hanspeter Stalder, Jasmine Portmann, Jenna Kelly, Silvio Steiner, View ORCID ProfileMelle Holwerda, Annika Kratzel, Mitra Gultom, Laura Laloli, Linda H?sser, Manon Wider, Stephanie Pfaender, Dagny Hirt, Valentina Cipp?, Silvia Crespo-Pomar, Simon Schr?der, Doreen Muth, Daniela Niemeyer, Marcel A. M?ller, Christian Drosten, View ORCID ProfileRonald Dijkman, Joerg Jores, Volker Thiel
doi: https://doi.org/10.1101/2020.02.21.959817

https://www.biorxiv.org/content/10.1...02.21.959817v1
 
Last edited:
Kathy there is a big difference between copying the existing gene sequence and making a very different sequence engineered to behave in a different way. If you look at the Spike gene section in this post you should see just how much extra genetic code you would need to get to SARS-CoV-2 from a bat SL beta CoV. https://flutrackers.com/forum/forum/...rsonal-opinion
 
Last edited by a moderator:
JJackson: I aligned the aa sequence of the spike protein of RaTG13 with the aa sequence of SARS-CoV-2 and the only gap that I see is the furin cleavage site, but maybe I am wrong, I am not a virologist. The RBD of the two sequences is quite different, but there are published methods to make chimeric viruses. A possibility would be to combine a sequence similar to RaTG13 (who knows how many sequences are not made public) with a sequence similar to the corona virus found in pangolin.

Regarding my post on the Swiss lab, I just wanted to show that almost all is possible nowadays in genetic engineering and it should be taken in consideration.

Please have a look at this link:
https://www.edge.org/conversation/william_mcewan-molecular-cut-and-paste

William McEwan: This afternoon I received in the post a slim FedEx envelope containing four small vials of DNA. The DNA had been synthesized according to my instructions in under three weeks, at a cost of 39 U.S. cents per base pair (the rungs adenine-thymine or guanine-cytosine in the DNA ladder). The 10 micrograms I ordered are dried, flaky, and barely visible to the naked eye, yet once I have restored them in water and made an RNA copy of this template, THEY WILL ENCODE A VIRUS I HAVE DESIGNED. …

I am interested in opinions about it. Is that really possible? I was myself surprised when I read it.
 
I am not a virologist either just an interested amateur.
The sequences I show aligned at the link include all the SL beta CoVs that I am aware of and I doubt anymore old sequences will come to light. RaTG13 was a sequence that had not been uploaded to either Genbank or GISAID until after the outbreak but anyone with anymore will have come forward by know (there is more on RaTG13 at https://flutrackers.com/forum/forum/...-ncov-genetics and Virological.org). Cut'n'paste could allow the creation of SARS-1 from the bat sequences and you could try adding in the furin cleavage site and may end up with high CFR version with SARS-CoV-2 transmissiblity. The real problem I foresee is in the improvement in computer modeling being used for drug interaction, once this reaches a point you can look at a sequence and accurately predict how it will behave in vivo then you could create something truly nasty from scratch. Unfortunately the article does not say if the virus he created actually did what he hoped for, or what virus he started with, I assume the jelly fish provided the fluorescence and he is trying to make a phage.
 
Here another article that denies a possible genetic manipulation of SARS-CoV-2:

http://virological.org/t/the-proximal-origin-of-sars-cov-2/398

It has really weak arguments, but could influence anyway public opinion.

As molecular biologist, and producing myself mutants (i do not work with pathogens though), I am aware of the huge risk connected with this kind of research. We need more strict regulations all over the world and more transparency.
 
Welcome, I am glad you decided to join up and post. I look forward to posts from you in the future and correct me if you see anything I have written which is wrong. I try and make constructive comments but my knowledge only goes so far and would hate to be misleading others.
 
Last edited:
Thank you JJackson! I am also very glad to be part of this community. It is great to have the possibility to exchange information and knowledge.

Regarding "cut'n'paste" of CoVs, I have found another interesting article.

A Mouse Model for Betacoronavirus Subgroup 2c Using a Bat
Coronavirus Strain HKU5 Variant
Sudhakar Agnihothram,a Boyd L. Yount, Jr.,a Eric F. Donaldson,a Jeremy Huynh,a Vineet D. Menachery,a Lisa E. Gralinski,a
Rachel L. Graham,a Michelle M. Becker,b Sakshi Tomar,d Trevor D. Scobey,a Heather L. Osswald,e Alan Whitmore,a Robin Gopal,c
Arun K. Ghosh,e Andrew Mesecar,d Maria Zambon,c Mark Heise,a Mark R. Denison,b Ralph S. Barica
Departments of Epidemiology and Microbiology and Immunology, University of North Carolina, Chapel Hill, North Carolina, USAa; Departments of Pediatrics and
Pathology and Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USAb; Viral Zoonosis Unit, Public Health of England, London, United Kingdomc;
Department of Chemistry, Purdue University, West Lafayette, Indiana, USAd; Departments of Chemistry and Medicinal Chemistry, Purdue University, West Lafayette,
Indiana, USA

https://mbio.asm.org/content/5/2/e00047-14

IMPORTANCE The 2012 outbreak of MERS-CoV raises the specter of another global epidemic, similar to the 2003 SARS-CoV epidemic. MERS-CoV is related to BtCoV HKU5 in target regions that are essential for drug and vaccine testing. Because no small animal model exists to evaluate MERS-CoV pathogenesis or to test vaccines, we constructed a recombinant BtCoV HKU5 that expressed a region of the SARS-CoV spike (S) glycoprotein, thereby allowing the recombinant virus to grow in cell culture and in mice. We show that this recombinant virus targets airway epithelial cells and causes disease in aged mice. We use this platform to (i) identify a broad-spectrum antiviral that can potentially inhibit viruses closely related to MERS-CoV, (ii) demonstrate the absence of increased eosinophilic immune pathology for MERS-CoV N protein-based vaccines, and (iii) mouse adapt this virus to identify viral genetic determinants of cross-species transmission and virulence. This study holds significance as a strategy to control newly emerging viruses.


It looks like that genetic manipulation of CoVs spike proteins has been widely used since many years and not only in China. I have found a patent for making such chimeras.
Title: Methods and compositions for chimeric coronavirus spike proteins United States Patent 9884895 Inventors: Baric, Ralph (Haw River, NC, US) Agnihothram, Sudhakar (Ellicott City, MD, US) Yount, Boyd (Hillsborough, NC, US) Publication Date: 02/06/2018
Assignee:
The University of North Carolina at Chapel Hill (Chapel Hill, NC, US)
 
Back
Top